Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2006 / Cilt: 17 - Sayı: 1

Evaluation of osteoporosis in early and late postmenopausal women: correlations between bone mineral density and bone turnover markers

Menopoz sonrası erken ve geç dönemde osteoporoz değerlendirmesi: Kemik mineral yoğunluğu ile kemik döngüsü belirteçleri arasındaki ilişki

Pages
28–32
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Concentrations of bone turnover markers were similar in both groups.Conclusion: Incorporation of bone turnover markers, in particular bone resorption markers into BMD analysis might be more useful in assessing bone turnover and bone loss rates at an earlier stage in postmenopausal osteoporosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to seek correlations between bone mineral density (BMD) and biochemical markers of bone turnover during early and late postmenopausal period.
📊
Key Findings & Data:Materials and methods: The study included 64 postmenopausal women (mean age 56.5 years; range 41 to 75 years) who did not have any disease or receive treatment that might affect bone metabolism and bone turnover, respectively.
💡
Conclusion & Impact:Concentrations of bone turnover markers were similar in both groups.Conclusion: Incorporation of bone turnover markers, in particular bone resorption markers into BMD analysis might be more useful in assessing bone turnover and bone loss rates at an earlier stage in postmenopausal osteoporosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to seek correlations between bone mineral density (BMD) and biochemical markers of bone turnover during early and late postmenopausal period. Materials and methods: The study included 64 postmenopausal women (mean age 56.5 years; range 41 to 75 years) who did not have any disease or receive treatment that might affect bone metabolism and bone turnover, respectively. The participants were divided into two age groups, namely 41 to 60 years of age (n=40), and beyond 60 years of age (n=24). The mean postmenopausal period was 5.3 years in group 1, and 16.7 years in group 2. Serum levels of estrogen, progesterone, parathormone, osteocalcin, and urinary deoxypridinoline (DPD) were measured and serum C-terminal telopeptide of the alpha-1 chain of type I collagen (CTx), calcium, and alkaline phosphatase levels were determined. Analysis of BMD was made by a dual-energy x-ray absorptiometry (DEXA) densitometer.Results: Positive correlations were found between serum osteocalcin, serum CTx, and urinary DPD. A negative correlation with age existed for BMD of the femoral neck, but not for BMD of the spine. Concentrations of bone turnover markers were similar in both groups.Conclusion: Incorporation of bone turnover markers, in particular bone resorption markers into BMD analysis might be more useful in assessing bone turnover and bone loss rates at an earlier stage in postmenopausal osteoporosis.

Özet

Amaç: Bu çalışmada menopoz sonrası erken ve geç dönemde kemik mineral yoğunluğu (KMY) ile kemik döngüsünü gösteren biyokimyasal belirteçler arasındaki ilişki araştırıldı. Olgular ve yöntemler: Çalışmaya, kemik metabolizmasını etkileyen herhangi bir hastalığı olmayan ve kemik döngüsünü etkileyecek tibbi bir tedavi görmeyen menopoz geçirmiş 64 kadın (ort. yaş 56.5; dağılım 41-75) alındı. Olgular 41-60 yaşları arasında olanlar (n=40) ve 60 yaşından büyük olanlar (n=24) şeklinde iki gruba ayrıldı. Menopozdan sonra geçen süre grup 1'de ortalama 5.3 yıl, grup 2'de 16.7 yıl idi. Tüm olgularda serum östrojen, progesteron, parathormon, osteokalsin ve idrar deoksipridinolin (DPD) düzeyleri ölçüldü. Ayrıca, tip I kollajenin alfa 1 zincirinde serum C-terminal telopeptit (CTx), kalsiyum ve alkalen fosfataz düzeyleri ölçüldü. Kemik mineral yoğunluğu ölçümü dual enerjili X-ray absorbsiometre (DEXA) ile yapıldı.Bulgular: Serum osteokalsin düzeyi, serum CTx ve idrar DPD değerleri arasında pozitif korelasyon bulundu. Femur boynu KMY ölçümü yaş ile negatif korelasyon gösterirken, omurga ölçümünde bu korelasyon yoktu. Kemik döngüsü belirteçleri her iki grupta benzer düzeylerdeydi.Sonuç: Özellikle yıkım ürünleri olmak üzere, KMY belirteçleri ile KMY analizlerinin birlikte değerlendirilmesi, kemik döngüsünün hızı ve menopoz sonrası erken dönemde yıkım hızını göstermesi açısından değerli olabilir.

🔖

Cite This Article

ÇULLU, E., YÜREKLİ, Y., ÖZKAN, İ., ALPARSLAN, B., OKYAY, P., KOZACI, D. L., ŞAVK, Ş. Ö. (2022). Evaluation of osteoporosis in early and late postmenopausal women: correlations between bone mineral density and bone turnover markers. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 17 - Sayı: 1, 28–32. https://ajindex.com/articles/498838

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Torgerson D, Gosden T, Reid D. The economics of osteoporosis prevention. Trends Endocrinol Metab 1997;8:236-9
  2. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med 1997;103(2A): 20S-25S
  3. Frost HM. The role of changes in mechanical usage set points in the pathogenesis of osteoporosis. J Bone Miner Res 1992;7:253-61
  4. Weaver CM, Teegarden D, Lyle RM, McCabe GP, McCabe LD, Proulx W, et al. Impact of exercise on bone health and contraindication of oral contraceptive use in young women. Med Sci Sports Exerc 2001;33: 873-80
  5. Sarrel PM. Androgen deficiency: menopause and estrogen- related factors. Fertil Steril 2002;77 Suppl 4:S63-7
  6. Hadjidakis DJ, Kokkinakis EP, Sfakianakis ME, Raptis SA. Bone density patterns after normal and premature menopause. Maturitas 2003;44:279-86
  7. Sirola J, Kroger H, Honkanen R, Jurvelin JS, Sandini L, Tuppurainen MT, et al. Factors affecting bone loss around menopause in women without HRT: a prospective study. Maturitas 2003;45:159-67
  8. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8 Suppl 2:S549-55
  9. Delmas P. Biochemical markers for the assessment of bone turnover. In: Riggs BL, Melton LJ 3rd, editors. Osteoporosis: etiology, diagnosis and management. 2nd ed. Philadelphia: Lippincott-Raven; 1995. p. 319-33
  10. Kawana K, Takahashi M, Hoshino H, Kushida K. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis. Clin Chim Acta 2002;316:109-15
  11. Ross PD, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998;13:297-302
  12. Demiaux B, Arlot ME, Chapuy MC, Meunier PJ, Delmas PD. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab 1992;74:1146-51
  13. Merle B, Delmas PD. Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget’s disease of bone. Bone Miner 1990;11:237-45
  14. Ahlborg HG, Johnell O, Nilsson BE, Jeppsson S, Rannevik G, Karlsson MK. Bone loss in relation to menopause: a prospective study during 16 years. Bone 2001;28:327-31
  15. Arnaud CD. Osteoporosis: using ‘bone markers’ for diagnosis and monitoring. Geriatrics 1996;51:24-30
  16. Karasik D, Cupples LA, Hannan MT, Kiel DP. Age, gender, and body mass effects on quantitative trait loci for bone mineral density: the Framingham Study. Bone 2003;33:308-16
  17. Westfall